C21 Investments Inc. (CXXIF)
OTCMKTS · Delayed Price · Currency is USD
0.3708
+0.0192 (5.46%)
Aug 21, 2025, 3:57 PM EDT
C21 Investments Revenue
C21 Investments had revenue of $8.55M in the quarter ending June 30, 2025, with 29.67% growth. This brings the company's revenue in the last twelve months to $32.08M, up 11.49% year-over-year. In the fiscal year ending March 31, 2025, C21 Investments had annual revenue of $30.12M with 12.42% growth.
Revenue (ttm)
32.08M
Revenue Growth
+11.49%
P/S Ratio
1.30
Revenue / Employee
232.43K
Employees
138
Market Cap
41.63M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 30.12M | 3.33M | 12.42% |
Mar 31, 2024 | 26.79M | -1.50M | -5.29% |
Jan 31, 2024 | 28.29M | -603.21K | -2.09% |
Jan 31, 2023 | 28.89M | -4.09M | -12.41% |
Jan 31, 2022 | 32.98M | -483.09K | -1.44% |
Jan 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |
C21 Investments News
- 10 months ago - Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close - Benzinga
- 10 months ago - C21 Investments Announces Q2 Earnings Date and Provides Operational Update - Newsfile Corp
- 1 year ago - C21 Investments Provides MCTO Status Update - Newsfile Corp
- 1 year ago - Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management - Benzinga
- 1 year ago - C21 Investments Announces Change to Financial Year-End, Delay in Filing Annual Financial Results and Application for Management Cease Trade Order - Newsfile Corp
- 1 year ago - C21 Announces Closing of C$4 Million Private Placement of Convertible Debenture Units - Newsfile Corp
- 2 years ago - Reasons To Be Cautiously Optimistic About Cannabis - Seeking Alpha
- 2 years ago - CSE Bulletin: Reinstatement - C21 Investments Inc. (CXXI) - Newsfile Corp